Location History:
- Santa Clara, CA (US) (2005 - 2006)
- Shanghai, CN (2011)
Company Filing History:
Years Active: 2005-2011
Title: Beihan Wang: Innovator in Antiviral Compounds
Introduction
Beihan Wang is a notable inventor based in Santa Clara, CA (US). He has made significant contributions to the field of antiviral compounds, holding a total of 4 patents. His work focuses on developing innovative solutions for treating viral infections, particularly Hepatitis C.
Latest Patents
Among his latest patents, Wang has developed heterocyclic antiviral compounds that serve as Hepatitis C virus NS5b polymerase inhibitors. These compounds are characterized by a specific formula, wherein R, R, R, R, R, Y, and p are defined, and C2-C3 can be a single or double bond. Additionally, he has disclosed compositions and methods for treating HCV infections and inhibiting HCV replication. Another significant patent involves CCR-3 receptor antagonists, which includes compounds of Formula (I) that are designed to act as CCR-3 receptor antagonists. This invention also encompasses pharmaceutical compositions containing these compounds, methods for their use, and intermediates useful for their preparation.
Career Highlights
Wang has worked with prominent companies in the pharmaceutical industry, including Roche Palo Alto LLC and Syntex (U.S.A.) Inc. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Throughout his career, Beihan Wang has collaborated with notable colleagues such as Daisy Joe Du Bois and Denis John Kertesz. These partnerships have likely enhanced his research and development efforts in the field of antiviral therapies.
Conclusion
Beihan Wang's contributions to antiviral compounds and his innovative patents highlight his role as a significant inventor in the pharmaceutical industry. His work continues to impact the treatment of viral infections, showcasing the importance of innovation in healthcare.